Opthea Ltd. Files August Corporate Update (6-K)
Ticker: OPTEY · Form: 6-K · Filed: Aug 19, 2025 · CIK: 1815620
Sentiment: neutral
Topics: corporate-update, 6-k
TL;DR
Opthea Ltd. dropped its August corporate update via 6-K filing, check Exhibit 99.1 for deets.
AI Summary
Opthea Ltd. filed a Form 6-K on August 19, 2025, reporting a corporate update for August 2025. The filing includes Exhibit 99.1, which details the corporate update. Opthea Limited is a biotechnology company focused on developing novel therapies for serious eye conditions.
Why It Matters
This filing provides investors with the latest information directly from Opthea Ltd. regarding its business and strategic developments, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine corporate update filing and does not contain significant new financial or operational risks.
Key Players & Entities
- Opthea Ltd (company) — Registrant
- August 19, 2025 (date) — Filing Date
- August 2025 (date) — Reporting Period
- Exhibit 99.1 (document) — Corporate Update Details
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a corporate update from Opthea Limited for the month of August 2025, as detailed in Exhibit 99.1.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed with the SEC on August 19, 2025.
What is the filing number for Opthea Limited's report?
The commission file number for Opthea Limited's report is 001-39621.
Where is Opthea Limited's principal executive office located?
Opthea Limited's principal executive office is located at Level 4, 650 Chapel Street, South Yarra, Victoria, 3141, Australia.
What exhibit contains the corporate update information?
Exhibit 99.1 contains the corporate update information for Opthea Limited.
Filing Stats: 143 words · 1 min read · ~1 pages · Grade level 13 · Accepted 2025-08-19 06:01:56
Filing Documents
- opt_-_opthea_august_upda.htm (6-K) — 27KB
- opt-ex99_1.htm (EX-99.1) — 60KB
- img260626642_0.jpg (GRAPHIC) — 151KB
- img260626642_1.jpg (GRAPHIC) — 151KB
- 0000950170-25-109921.txt ( ) — 504KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 08/18/2025